טוען...

Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide Analog

INTRODUCTION: Aspirin may reduce the risk of chronic hepatitis B (CHB)-related hepatocellular carcinoma (HCC) in patients receiving antiviral treatment. We aimed to investigate the impact of aspirin on reducing HCC risk in patients treated with first-line oral nucleos(t)ide analogs (NAs; entecavir a...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Clin Transl Gastroenterol
Main Authors: Hui, Vicki Wing-Ki, Yip, Terry Cheuk-Fung, Wong, Vincent Wai-Sun, Tse, Yee-Kit, Chan, Henry Lik-Yuen, Lui, Grace Chung-Yan, Wong, Grace Lai-Hung
פורמט: Artigo
שפה:Inglês
יצא לאור: Wolters Kluwer 2021
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC8126482/
https://ncbi.nlm.nih.gov/pubmed/33750746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ctg.0000000000000324
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!